Healthcare Moves: A Monthly Summary of Hires and Layoffs
Here is a selection of recent executive hires, retirements, promotions and layoffs occurring across the healthcare industry.
Liquid Biopsy Startup Precede Sets Out to Make Precision Medicine More Precise
Precede Biosciences’ liquid biopsy platform yields insight into the genes and pathways in diseased tissue. Based on Dana-Farber Cancer Institute research, the startup aims to support biopharma drug R&D as it also develops the technology for clinical care applications.
Reducing Clinical and Staff Burnout with AI Automation
As technology advances, AI-powered tools will increasingly reduce the administrative burdens on healthcare providers.
How Boston has transformed itself into a powerful digital health ecosystem
Brigham and Women’s hospital has also launched a digital innovation hub called iHub that works with clinicians, researchers, and staff to accelerate and commercialize digital health ideas.
Dana-Farber’s John Quackenbush on how to fix our “messy data” problem
On day two of MedCity CONVERGE, John Quackenbush of the Dana-Farber Cancer Institute highlighted the benefits and the challenges that accompany big data.
From malls to medicine: What’s happening to empty retail space?
The brick-and-mortar retail industry isn't doing well. As shopping malls clear out, landlords are finding medical providers eager to take over the empty mall space.
Fitbit, Dana-Farber to study whether weight loss prevents breast cancer recurrence
The goal is to see if the extra motivation from fitness trackers, Wi-Fi scales and health coaches can help the patients lose weight and, ultimately, prevent a return of the disease.
presented by
Transforming Patient Care: The Role of AI-Powered Assistants
The progress in artificial intelligence (AI) is reshaping patient care, across various dimensions, from facilitating faster discharge to curating treatment plans and suggesting lifestyle changes.
How effective is genetic testing if doctors aren’t always sure how to interpret it?
“Our ability to sequence genes has gotten ahead of our ability to know what it means,” said Eric P. Winer, the director of the breast oncology program at Harvard’s Dana-Farber Cancer Institute.
C4 Therapeutics launches with $73M Series A for new cancer treatment approach
The startup created from Dana-Farber Cancer Institute announced today the closing of a $73 million Series A round of financing and a promising partnership with Roche.
New male birth control options in the works
Women have been largely in charge of making sure unwanted pregnancies don’t happen unexpectedly due to the availability of various forms of contraception. While men have the obvious choice of using condoms or in extreme cases going for the snip (and there have been talks of a future pill-form for men), other potentially affective options […]
ESPN’s Stuart Scott symbolized the ‘fighter persona’ of cancer patients
ESPN anchor Stuart Scott died Sunday morning at the age of 49 after an eight-year battle with cancer. He was, in many ways, bigger than ESPN itself: he was one of the network’s most popular personalities, and his unique booyah catchphrases inspired a generation of broadcasters. So it’s no surprise that his approach to […]
Health Executives on Digital Transformation in Healthcare
Hear executives from Quantum Health, Surescripts, EY, Clinical Architecture and Personify Health share their views on digital transformation in healthcare.
A whopping $53.1M Series B will help Syros Pharmaceuticals advance toward clinic for cancer
Gene regulation startup Syros Pharmaceuticals has raised a $53.1 million from 16 investors, according to regulatory filings. This financing round was led by “a large, Boston-based public investment firm,” also includes new investors Polaris Partners, Aisling Capital and Redmile Group. The current investors – Flagship Ventures, ARCH Venture Partners, WuXi PharmaTech Corporate Ventuer Fund and […]
More research hospitals’ tech transfer offices are now business development offices, too
In the same way that funding for early-stage innovations is changing, so is how those innovations are translated from the bench to the bedside. “Our office, which was formerly a traditional tech transfer office, has very much become a business office,” said Gary Sclar from the Dana-Farber Cancer Institute’s Office of Research and Technology Ventures. […]